Hye Ryun Kim - Publications, H-index & Citations

Hye Ryun Kim

Yonsei University College of Medicine

60H指数

749论文数

1.8W被引数

收录论文 181

发表时间

EpCAM+ Extracellular Vesicle PD-L1 Dynamics as a Predictive Biomarker of Immune Checkpoint Blockade Response EpCAM阳性外泌体PD-L1动力学作为预测免疫检查点阻断反应的生物标志物

Advanced Science

IF14.1

2026-07-03

OAAI

Byeonggeol Mun; Jinyoung Kim; Chang Gon Kim; Seokhyeong Go; Mina Han; Yujin Ouck; Soojin Jang; Seong Uk Son; Gamin Kim; Wonrak Son; Eunjung Kim; Min Hee Hong; Ja Hyun Yeo; Eun-Kyung Lim; Hye Ryun Kim; Seungjoo Haam

Atezolizumab and bevacizumab plus chemotherapy versus chemotherapy in non-small cell lung cancer after tyrosine kinase inhibitor failure 阿替利珠单抗和贝伐珠单抗联合化疗与化疗在酪氨酸激酶抑制剂失败后的非小细胞肺癌中的比较

Therapeutic Advances in Medical Oncology

IF4.2

2026-06-26

PREAI

Moonki Hong; Junho Choi; Seoyoung Lee; Yun Beom Sang; Min Hee Hong; Ja Hyun Yeo; Joo-Hang Kim; Shinkyo Yoon; Chang Gon Kim; Hye Ryun Kim

TROPION-Lung14 study protocol: a phase III study of osimertinib in combination with datopotamab deruxtecan versus osimertinib alone as first-line treatment for patients with EGFR -mutated locally advanced or metastatic non-small cell lung cancer TROPION-Lung14研究方案：一项关于奥希替尼联合达托帕姆德鲁克坦与奥希替尼单药作为携带EGFR突变局部晚期或转移性非小细胞肺癌患者一线治疗的III期研究

Therapeutic Advances in Medical Oncology

IF4.2

2026-05-20

PREAI

Shun Lu; Mariano Provencio Pulla; Eldsamira Mascarenhas; Junko Tanizaki; Hye Ryun Kim; Yinglei Liu; Shengmei Feng; Biao Zhang; Laurence Toms; James Chih-Hsin Yang; Sarah B. Goldberg

IC-TCA-Net: a multimodal fusion framework with dimensionality transformation for two-year recurrence prediction in NSCLC IC-TCA-Net：一种带维度变换的多模态融合框架，用于NSCLC两年复发预测

Biomedical Engineering Letters

IF2.8

2026-05-13

PREAI

Hye Ryun Kim; Kyongmin Sarah Beck; Jin Hyoung Kang; Helen Hong

Nivolumab plus chemoradiotherapy followed by nivolumab with or without ipilimumab for untreated locally advanced stage III NSCLC: a randomized phase 3 trial 纳武利尤单抗联合放化疗后序贯纳武利尤单抗联合或不联合伊匹木单抗治疗未经治疗的局部晚期Ⅲ期非小细胞肺癌：一项随机Ⅲ期试验

Nature Cancer

IF28.5

2026-05-13

OAAI

Solange Peters; Daniel S. W. Tan; David E. Gerber; James Urbanic; Suresh Ramalingam; Jinming Yu; Ligang Xing; Achim Rittmeyer; Tudor-Eliade Ciuleanu; Juliana de Menezes; Hye Ryun Kim; Carlos Rojas; Konstantinos Syrigos; Hidetoshi Hayashi; Anoop Haridass; Diego Cortinovis; Debora Bruno; Martin Kimmich; Antonio Calles; Raheel Nathani; Geetha Pudussery; Luoying Yang; Dirk De Ruysscher

of Asia: Provision of Patient-Centered Care in Oral Cavity Cancer: A Qualitative Study With Patients, Caregivers, and Healthcare Professionals in Five Asia-Pacific Regions 亚洲：口腔癌患者为中心的护理提供：一项涉及五个亚太地区患者、护理人员和医疗专业人员的定性研究

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

IF1.6

2025-11-01

OAAI

Hui, Edwin Pun; Sundaresan, Puma; Kim, Hye Ryun; Nguyen, Khoi Tuan; Nicholls, Tracey E.; Teng, Hai-Ling; Li, Yu-Chung; Yew, Ying Jie; Gowindah, Regina; Stylianou, Con; Lou, Pei-Jen

A phase II clinical trial of paclitaxel-carboplatin as neoadjuvant therapy followed by surgery in patients with locally advanced head and neck squamous cell carcinoma 一项将紫杉醇-卡铂作为新辅助治疗，随后进行手术的II期临床试验，针对局部晚期头颈部鳞状细胞癌患者

Oral Oncology

IF3.9

2025-10-11

PREAI

Min Hee Hong; Seoyoung Lee; Chang Gon Kim; Wonrak Son; Jin Woo Park; Sun Och Yoon; Su-Jin Shin; Hyun Jun Hong; Yoon Woo Koh; Jae-Yol Lim; Young Min Park; Chan Woo Wee; Kyung Hwan Kim; Chang Geol Lee; Jun Won Kim; Jinna Kim; Pae Sun Suh; Sung Uk Kuh; Da Hee Kim; Nam Suk Sim; Hye Ryun Kim

Differential Efficacy of Alpelisib by PIK3CA Mutation Site in Head and Neck Squamous Cell Carcinoma: An Analysis from the KCSG HN 15-16 TRIUMPH Trial 头颈部鳞状细胞癌中Alpelisib对不同PIK3CA突变位点的差异性疗效：来自KCSG HN 15-16 TRIUMPH试验的分析

CANCER RESEARCH AND TREATMENT

IF3.8

2025-10-01

PREAI

Kim, Kyoo Hyun; Hwang, Shinwon; Kim, Min Kyoung; Park, Keon-Uk; Yun, Tak; Lee, Keun-Wook; Kim, Joo Hang; Keam, Bhumsuk; Cho, Byoung Chul; Oh, So Yeon; Cho, Sang Hee; Kim, Sangwoo; Kim, Sung-Bae; Hong, Min Hee; Kim, Hye Ryun

Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer Sevabertinib治疗晚期HER2-Mutant非小细胞肺癌

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2025-10-01

PREAI

Le, Xiuning; Kim, Tae Min; Loong, Herbert H.; Prelaj, Arsela; Goh, Boon Cher; Li, Lin; Fang, Yong; Lu, Shun; Dong, Xiaorong; Wu, Lin; Shinno, Yuki; Daniele, Gennaro; Yang, Tsung-Ying; Kim, Hye Ryun; Ruiter, Gerrina; Zhao, Jun; Novello, Silvia; Miao, Liyun; Janne, Pasi A.; Goto, Koichi; Ruttinger, Dominik; Descamps, Tine; Brase, Jan Christoph; Bao, Weichao; Li, Rui; Brega, Nicoletta; Grassi, Paolo; Girard, Nicolas; Tan, Daniel Shao-Weng

Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum 基于常规临床、实验室和病理参数的转移性或不可切除食管癌患者接受一线抗PD-1联合氟嘧啶和铂类药物治疗的真实世界结局与生物标志物分析

Cancers 2025, Vol. 17, Page 3149

IF4.4

2025-09-28

OAAI

Jiyun Jeong; Seyoung Seo; Sung-Bae Kim; Joon Seon Song; Hye Ryun Kim; Byoung Chul Cho; Minkyu Jung; Chang Gon Kim; Moonki Hong; Min Hee Hong; Sook Ryun Park

Identifying predictive markers of head and neck squamous cell carcinoma in an umbrella trial (KCSG HN 15-16 TRIUMPH trial)在伞形试验（KCSG HN 15-16 TRIUMPH试验）中识别头颈鳞状细胞癌的预测性生物标志物

ESMO Open

IF8.3

2025-09-17

PREAI

S. Hwang; M.H. Hong; S.H. Shin; T. Yun; K.-W. Lee; J.H. Kim; M.J. Ahn; B. Keam; H.W. Lee; M.K. Kim; H.J. Yun; Y. Kim; H.J. Kim; S.H. Cho; H.J. An; S.Y. Oh; S.-G. Park; Y.W. Koh; H.K. Ahn; J.H. Kwon; Y.-G. Lee; K.-U. Park; I.G. Hwang; S.-B. Kim; S. Kim; H.R. Kim

Optimizing management of stage IV EGFR mutant non-small cell lung cancer in Asia: An expert opinion 优化亚洲地区EGFR突变IV期非小细胞肺癌的管理：专家意见

International Journal of Cancer

IF4.7

2025-06-14

OAAI

Gee-Chen Chang; Akhil Kapoor; Chee Khoon Lee; Chunxia Su; Daniel Chan; Guia Elena Imelda Ladrera; Hye Ryun Kim; Mostafa Aziz Sumon

Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter Trial Lazertinib治疗不常见EGFR突变的NSCLC患者: 一项II期多中心试验

Journal of Thoracic Oncology

IF20.8

2025-05-09

OAAI

Sehhoon Park; Hee Kyung Ahn; Seoyoung Lee; Young Joo Min; Jinyong Kim; Hyun Ae Jung; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Myung-Ju Ahn; Jii Bum Lee; Sun Min Lim; Hye Ryun Kim; Byoung Chul Cho; Min Hee Hong

First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial 一线纳武利尤单抗联合铂类化疗和贝伐珠单抗治疗晚期非鳞非小细胞肺癌：TASUKI-52 III期随机试验3年随访

LUNG CANCER

IF4.4

2025-03-01

PREAI

Lee, Ki Hyeong; Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru

Th1-poised naive CD4 T cell subpopulation reflects anti-tumor immunity and autoimmune disease Th1-poised naive CD4 T细胞亚群反映抗肿瘤免疫和自身免疫病

NATURE COMMUNICATIONS

IF15.7

2025-02-25

OAAI

Yoon, Jae-Won; Kim, Kyung Min; Cho, Sookyung; Cho, Min-Ji; Park, Seonjun; Hwang, Daehee; Kim, Hye Ryun; Park, Sung Ho; Cho, Jae-Ho; Jeong, Hyobin; Choi, Je-Min

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with oncogene-addicted metastatic non-small-cell lung cancer 泛亚适应ESMO临床实践指南，用于癌基因成瘾的转移性非小细胞肺癌患者的诊断，治疗和随访

ESMO OPEN

IF8.3

2024-12-01

PREAI

Lee, S. -h.; Menis, J.; Kim, T. M.; Kim, H. R.; Zhou, C.; Kurniawati, S. A.; Prabhash, K.; Hayashi, H.; Lee, D. d. -w.; Imasa, M. S.; Teh, Y. L.; Yang, J. c. -h.; Reungwetwattana, T.; Sriuranpong, V.; Wu, C. -e.; Ang, Y.; Sabando, M.; Thiagarajan, M.; Mizugaki, H.; Noronha, V.; Yulianti, M.; Zhang, L.; Smyth, E.; Yoshino, T.; Park, J. O.; Pentheroudakis, G.; Park, S.; Peters, S.; Ahn, J. B.; Popat, S.

Phase II trial of lazertinib plus pemetrexed/carboplatin in patients with EGFR-mutant recurrent or metastatic nonsmall cell lung cancer who failed prior lazertinib (LUCAS): Interim analysis 拉泽替尼联合培美曲塞/卡铂治疗EGFR突变复发或转移性非小细胞肺癌且既往拉泽替尼治疗失败患者的II期试验（LUCAS研究）：中期分析

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Hong, M. H.; Kim, Y. S.; Ahn, H.; Lee, S.; Lee, Y.; Ahn, B-C.; Ahn, M-J.; Ahn, J. S.; Park, S.; Hong, S-H.; Shim, B. Y.; Lee, K. H.; Kim, C. G.; Kim, H. R.

Multifaceted challenges in patient-centered oral cavity cancer care: An Asia-Pacific cross-sectional study with patients, caregivers, and healthcare professionals 以患者为中心的口腔癌护理中的多方面挑战：一项涵盖患者、护理人员和医疗专业人员的亚太地区横断面研究

ANNALS OF ONCOLOGY

IF65.4

2024-12-01

PREAI

Hui, E. P.; Sundaresan, P.; Kim, H. R.; Tuan, K. Nguyen; Nicholls, T.; Teng, H-L.; Li, J.; Si, J.; Yew, Y. J.; Gowindah, R.; Stylianou, C.; Lou, P-J.

Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea

LUNG CANCER-TARGETS AND THERAPY

IF3.3

2024-10-01

OAAI

Shim, Joo Sung; Kim, Youhyun; Yuh, Taeho; Lee, Jii Bum; Kim, Hye Ryun; Hong, Min Hee; Cho, Byoung Chul; Lim, Sun Min

First-line lorlatinib vs crizotinib in Asian patients with ALK plus non-small cell lung cancer (NSCLC): 5-year outcomes from the CROWN study 一线洛拉替尼与克唑替尼在ALK阳性非小细胞肺癌（NSCLC）亚洲患者中的比较：CROWN研究5年结果

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Wu, Y-L.; Kim, H. R.; Soo, R. A.; Zhou, Q.; Akamatsu, H.; Chang, G-C.; Chiu, C. H.; Hayashi, H.; Kim, S-W.; Goto, Y.; Kato, T.; Zhou, J.; Lee, V. H. F.; Nishio, M.; Han, B.; Kim, D-W.; Lu, S.; Polli, A.; Martini, J-F.; Mok, T. S. K.

研究方向